Background: This study aimed to analyze the diagnostic reliability of radiographic assessment of cystic lesions using a pre-set, manufacturer-specific, low-dose mode compared to a standard-dose dental cone-beam computed tomography (CBCT) imaging protocol. Methods: Forty pig mandible models were prepared with cystic lesions and underwent both CBCT protocols on an Orthophos SL Unit (Dentsply-Sirona, Bensheim, Germany). Qualitative and quantitative analysis of CBCT data was performed by twelve investigators independently in SIDEXIS 4 (Dentsply-Sirona) using a trial-specific digital examination software tool. Thereby, the effect of the two dose types on overall detectability rate, the visibility on a scale of 1 (very low) to 10 (very high) and the difference between measured radiographic and actual lesion size was assessed. Results: Low-dose CBCT imaging showed no significant differences considering detectability (78.8% vs. 81.6%) and visibility (9.16 vs. 9.19) of cystic lesions compared to the standard protocol. Both imaging protocols performed very similarly in lesion size assessment, with an apparent underestimation of the actual size. Conclusion: Low-dose protocols providing confidential diagnostic evaluation with an improved benefit–risk ratio according to the ALADA principle could become a promising alternative as a primary diagnostic tool as well as for radiological follow-up in the treatment of cystic lesions.

The present study aimed to compare the diagnostic reliability of a pre-set, manufacturer-specific, low-dose mode against a standard-dose mode in the detection of four different osseous lesions in the mandible with cone-beam computed tomography (CBCT). Four types of lesions (periapical lesion, extended periodontal gap, recession of the buccal lamella, sequestrum/fracture) were prepared on 40 pig mandibles. CBCT images were obtained from each mandible, with both the low-dose and standard-dose modes using the Orthophos SL CBCT device (Dentsply-Sirona, Bensheim, Germany). Twelve assessors quantitatively (detection of lesions) and qualitatively (assessment of detectability) evaluated the CBCT images in SIDEXIS 4 (Dentsply-Sirona) using a study-specific digital examination tool. A correct diagnosis was achieved in almost 71% (LD: 70.8%; SD: 70.9%) of 1920 lesions, without a statistically significant difference between the low-dose and standard-dose mode. This finding was consistent across all four lesion types. In conclusion, while low-dose mode and standard-dose mode CBCT scans performed similarly in the detection of four prepared lesions of the mandible, the former may be a promising, user-friendly alternative method of obtaining radiation-optimized, three-dimensional images in accordance with the As Low As Diagnostically Acceptable (ALADA) principle.

No abstract